Startseite Semen Polymorphonuclear Neutrophil Leukocyte Elastase as a Diagnostic and Prognostic Marker of Genital Tract Inflammation – A Review
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Semen Polymorphonuclear Neutrophil Leukocyte Elastase as a Diagnostic and Prognostic Marker of Genital Tract Inflammation – A Review

  • Branko Zorn , Alenka Sešek-Briški , Joško Osredkar und Helena Meden-Vrtovec
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 41 Heft 1

Abstract

Elastase is a protease released by polymorphonuclear neutrophils (PMN) during the inflammatory process. Since 1987, seminal elastase-inhibitor complex (Ela/α1-PI) has been proposed as a marker of male silent genital tract inflammation. Measured by immunoassay in seminal plasma, Ela/α1-PI at a cut-off level of ≥230 μg/l, is useful in the detection of genital tract inflammation. The prevalence of increased seminal Ela/α1-PI in infertile men is significantly higher than that observed in fertile men. The Ela/α1-PI level is positively correlated with other seminal fluid markers of male genital tract inflammation: reduced semen volume, citric acid, fructose, and increased albumin, complement component C3, caeruloplasmin, immunoglobulins IgG and IgA, and cytokines interleukins-8 and -6. A higher seminal Ela/α1-PI level is significantly associated with tubal damage in female partners. After antibiotic therapy, a decrease of Ela/α1-PI level is observed. The presence of tubal damage in the partner may negatively affect the response to antibiotic treatment. A higher seminal Ela/α1-PI is associated with lower percentage of sperm with single-stranded deoxyribonucleic acid (DNA) and better fertilization rate in in vitro fertilization. Besides infertility, the determination of Ela/α1-PI is useful to confirm the presence of prostate and other male accessory gland bacterial inflammation. Screening for PMN Ela/α1-PI is easy to perform and reproducible and is a reliable quantitative test for diagnosis and prognosis of silent genital tract inflammation of couples. Moreover, sequential determinations allow the follow-up of inflammation during and after therapy.

:
Published Online: 2005-06-01
Published in Print: 2003-01-27

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. Evidence-Based Laboratory Medicine: Addressing Bias, Generalisability and Applicability in Studies on Diagnostic Accuracy. The STARD Initiative
  2. Semen Polymorphonuclear Neutrophil Leukocyte Elastase as a Diagnostic and Prognostic Marker of Genital Tract Inflammation – A Review
  3. Total Oxyradical Scavenging Capacity toward Different Reactive Oxygen Species in Seminal Plasma and Sperm Cells
  4. Identification of New Polymorphisms in the CACNA1S Gene
  5. 3-Nitrotyrosine in Atherosclerotic Blood Vessels
  6. Molecular Diagnosis of Cystic Fibrosis: Comparison of Four Analytical Procedures
  7. Assessment of Intestinal Permeability: Enzymatic Determination of Urinary Mannitol, Raffinose, Sucrose and Lactose on Hitachi Analyzer
  8. Effects of Calcium Carbonate, Magnesium Oxide and Sodium Citrate Bicarbonate Health Supplements on the Urinary Risk Factors for Kidney Stone Formation
  9. Glycerol Metabolism and the Determination of Triglycerides –Clinical, Biochemical and Molecular Findings in Six Subjects
  10. Plasma Lipid Composition and LDL Oxidation
  11. Modified Method to Measure Nasal Potential Difference
  12. Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
  13. Novel and Traditional Biomarkers of Bone Turnover in Postmenopausal Women
  14. Urinary Plasma Protein Patterns in Acute Prostatitis
  15. Adequate Sampling in Cryoglobulinaemia: Recommended Warmly
  16. A New Modification of the Chiron ACS Assay for Total Prostate-Specific Antigen Achieves Equimolar Response Characteristics and Improves the Detection of Prostate Cancer
  17. Technical Performance and Diagnostic Utility of the New Elecsys® Neuron-Specific Enolase Enzyme Immunoassay
  18. Measurements of Complement Factor H-Related Protein (BTA-TRAK™ Assay) and Nuclear Matrix Protein (NMP22 Assay) – Useful Diagnostic Tools in the Diagnosis of Urinary Bladder Cancer?
  19. Erratum: The 18th International Congress of Clinical Chemistry and Laboratory Medicine. Special Supplement Abstracts Issue 2002
  20. Meetings and Awards
Heruntergeladen am 29.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2003.002/html
Button zum nach oben scrollen